PRMT5 and hepatocellular carcinoma: In addition, HNF4α has been shown to re-differentiate HCC cells into hepatocytes and inhibits EMT, thereby blocking the occurrence of liver cancer, however, PRMT5 antagonizes the expression of HNF4α and helps maintain liver cancer stem cells (Wright et al., 2021).